Kangfeng Bio submits a prospectus to the Hong Kong Stock Exchange

Kangfeng Bio is a manufacturer of cryoablation devices and catheters. Focus on the application of cryotechnology in the field of innovative minimally invasive interventional medical devices in the cardiovascular field. Today, Kangfeng Bio submitted its prospectus to the Hong Kong Stock Exchange.

This article is reprinted from: https://www.itjuzi.com/pre-ipo?comname=%E5%BA%B7%E6%B2%A3%E7%94%9F%E7%89%A9
This site is for inclusion only, and the copyright belongs to the original author.

Leave a Comment

Your email address will not be published.